Pharma Sector Receives Temporary Relief from Tariffs, But Challenges Loom Ahead
For weeks, there has been ongoing speculation regarding the fate of pharmaceuticals within Donald Trump's extensive tariff policy overhaul.Surprisingly, drug products were omitted from the 20% taxes set to be enforced on exports from!--more-->…